Clinical Trials Browser

Phase 2 × Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Phase 2 Unknown

Neoplasms

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

Phase 2 Unknown

Neoplasms